cardiovascular-agents and Sclerosis

cardiovascular-agents has been researched along with Sclerosis* in 2 studies

Other Studies

2 other study(ies) available for cardiovascular-agents and Sclerosis

ArticleYear
[The indices of intracardiac hemodynamics in patients with postinfarct cardiosclerosis].
    Likars'ka sprava, 1999, Issue:5

    Endocardiac hemodynamics was studied in 81 patients with postinfarction cardiosclerosis with intact and decreased ejection fraction (EF > 57% and EF < 57% respectively) using echocardiographic B- and M-mode techniques. Patients with postinfarction cardiosclerosis without overt heart failure demonstrated a decline in the left ventricular pump function which was more manifest in postinfarction cardiosclerosis presenting with a decreased ejection fraction. A decline in the pump function of the myocardium in those patients having postinfarction cardiosclerosis without overt cardiac insufficiency is an indication for prescription of those medicinal substances enhancing the inotropic function of the myocardium (cardiac glycosides, peripheral vasodilators).

    Topics: Adult; Aged; Cardiovascular Agents; Drug Therapy, Combination; Echocardiography; Female; Heart; Hemodynamics; Humans; Male; Middle Aged; Myocardial Infarction; Myocardium; Sclerosis

1999
[Hypoxemia test in vegetative lability and coronary sclerosis and its influence by hydrated ergot alkaloid].
    Schweizerische medizinische Wochenschrift, 1951, Dec-22, Volume: 81, Issue:51

    Topics: Cardiovascular Agents; Coronary Artery Disease; Electrocardiography; Ergot Alkaloids; Humans; Hypoxia; Sclerosis

1951